Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 115 of 1,261
  1. US 11998639

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    AXSOME MALTA LTD. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  2. US 11999747

    Furoquinolinediones as inhibitors of TDP2

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  3. US 11998528

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  4. AU 2022390453

    NOVEL HETEROARYL-UREA COMPOUNDS AS KV7.2 INHIBITORS

    ANGELINI PHARMA S P A [IT] · Granted May 30, 2024 · Expires May 25, 2044

    granted
  5. US 11992472

    Compositions and methods for enhancing the efficacy of contraceptive microbicides

    Evofem, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  6. US 11992532

    Hydrogels and methods of using the same

    The Regents of the University of California · Granted May 28, 2024 · Expires May 23, 2044

    granted
  7. US 11992495

    Enhancing GABA's ability to modulate immune responses

    The Regents of the University of California · Granted May 28, 2024 · Expires May 23, 2044

    granted
  8. US 11993584

    Solid forms of an azolopyrimidine compound

    Arcus Biosciences, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  9. US 11992480

    Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  10. US 11992506

    Stem cell derived pancreatic islet differentiation

    Vertex Pharmaceuticals Incorporated · Granted May 28, 2024 · Expires May 23, 2044

    granted
  11. US 11993600

    Saturated spirocyclics as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  12. US 11993793

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Precision BioSciences, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  13. US 11993658

    Anti-BCMA antibodies and treatment methods

    Sutro Biopharma, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  14. US 11993644

    Antigen binding molecules targeting SARS-CoV-2

    Generate Biomedicines, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  15. US 11993569

    3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases

    Northwestern University · Granted May 28, 2024 · Expires May 23, 2044

    granted
  16. US 11993603

    Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted May 28, 2024 · Expires May 23, 2044

    granted
  17. US 11993580

    Methods of treating neurological disorders

    Neumora Therapeutics, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  18. US 11992530

    Therapeutic uses for sodium thiosulfate and formulations

    Fennec Pharn ceuticals Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  19. US 11993570

    Cationic lipids

    Takeda Pharmaceutical Company Limited · Granted May 28, 2024 · Expires May 23, 2044

    granted
  20. US 11993594

    IRAK inhibitors and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  21. US 11993638

    GM-CSF mimetics and methods of making and using same

    The Regents of the University of Colorado, a Body Corporate · Granted May 28, 2024 · Expires May 23, 2044

    granted
  22. US 11993660

    Chimeric polypeptides and methods of altering the membrane localization of the same

    Cell Design Labs, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  23. US 11992531

    C3-carbon linked glutarimide degronimers for target protein degradation

    C4 THERAPEUTICS, INC. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  24. US 11992555

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted May 28, 2024 · Expires May 23, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.